Pharma 3.0 : delivering on health outcomes

The article offers information on the latest developments which are taking place in the pharmaceutical industry in Europe. It mentions that the industry is spending time and money in reshaping the industry in terms of health care system and health facilities offered to patients. It informs that phar...

Authors: Flochel, Patrick
Kumli, Frank
Document types:Article
Media types:Text
Publication date:2010
Date of publication on miami:16.09.2010
Modification date:24.03.2023
Source:Journal of Business Chemistry, 7 (2010) 3, S. 155-163
Edition statement:[Electronic ed.]
DDC Subject:330: Wirtschaft
License:InC 1.0
Language:English
Notes:Section "Practicioner’s Section"
Format:PDF document
URN:urn:nbn:de:hbz:6-86469448955
Permalink:https://nbn-resolving.de/urn:nbn:de:hbz:6-86469448955
Digital documents:2010_vol7_iss3_155-163.pdf

The article offers information on the latest developments which are taking place in the pharmaceutical industry in Europe. It mentions that the industry is spending time and money in reshaping the industry in terms of health care system and health facilities offered to patients. It informs that pharmaceutical companies are focusing on organizational realignment, biotechnology and personalized medicine.